ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Potassium hydroxy sulfite → tert-butyl ((1S,3R)-3-((3-carbamoyl-6-(5-(methylsulfinyl)-1,3,4-oxadiazol-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-1,2,2-trimethylcyclopentyl)carbamate

HRID 1408987
ノート
印刷プレビュー

反応式

HRID 1408987 の反応式
[C:1]([C:4]1[CH:9]=[N:8][N:7]2[CH:10]=[C:11]([C:13]3[O:14][C:15]([S:18][CH3:19])=[N:16][N:17]=3)[CH:12]=[C:6]2[C:5]=1[NH:20][C@@H:21]1[CH2:25][CH2:24][C@@:23]([NH:27][C:28](=[O:34])[O:29][C:30]([CH3:33])([CH3:32])[CH3:31])([CH3:26])[C:22]1([CH3:36])[CH3:35])(=[O:3])[NH2:2].[OH:37]OS([O-])=O.[K+]>CC(C)=O.O.CCOC(C)=O>[C:1]([C:4]1[CH:9]=[N:8][N:7]2[CH:10]=[C:11]([C:13]3[O:14][C:15]([S:18]([CH3:19])=[O:37])=[N:16][N:17]=3)[CH:12]=[C:6]2[C:5]=1[NH:20][C@@H:21]1[CH2:25][CH2:24][C@@:23]([NH:27][C:28](=[O:34])[O:29][C:30]([CH3:33])([CH3:32])[CH3:31])([CH3:26])[C:22]1([CH3:36])[CH3:35])(=[O:3])[NH2:2]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 2

HCID 23707502Potassium hydroxy sulfiteHCID 86707719tert-butyl ((1S,3R)-3-((3-carbamoyl-6-(5-(methylthio)-1,3,4-oxadiazol-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-1,2,2-trimethylcyclopentyl)carbamate

生成物 1

HCID 86707720tert-butyl ((1S,3R)-3-((3-carbamoyl-6-(5-(methylsulfinyl)-1,3,4-oxadiazol-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-1,2,2-trimethylcyclopentyl)carbamate収率 23%

試薬・触媒・溶媒 3

HCID 180
Acetone
溶媒
HCID 962Water溶媒
HCID 8857Ethyl Acetate溶媒

実験手順

A solution of tert-butyl ((1S,3R)-3-((3-carbamoyl-6-(5-(methylthio)-1,3,4-oxadiazol-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-1,2,2-trimethylcyclopentyl)carbamate (805 mg, 1.561 mmol) in acetone (16 mL) was added oxone (1.920 g, 3.12 mmol) in water (16.00 mL) and stirred for 2 hrs. The reaction mixture was diluted with 150 mL of EtOAc which was washed with 50 mL of 10% LiCl solution, 50 mL of brine and dried over Na2SO4. Filtration and concentration yielded a crude product which was purified on silica gel column with EtOAc to give tert-butyl ((1S,3R)-3-((3-carbamoyl-6-(5-(methylsulfinyl)-1,3,4-oxadiazol-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-1,2,2-trimethylcyclopentyl)carbamate (186.6 mg, 23% yield). HPLC retention time=2.993 min. LC-MS: M+1 532.3. 1H-NMR (400 MHz, methanol-d4) δ 8.30 (d, J=1.8 Hz, 1H), 8.26 (s, 1H), 7.51 (d, J=1.8 Hz, 1H), 4.50 (d, J=9.0 Hz, 1H), 3.31 (s, 3H, under MeOH peak), 2.51-2.32 (m, 1H), 2.29-2.13 (m, 1H), 2.12-1.95 (m, 1H), 1.83-1.63 (m, 1H), 1.49 (s, 3H), 1.46 (s, 9H), 1.13 (s, 3H), 1.09 (s, 3H).

後処理

  1. washwas washed with 50 mL of 10% LiCl solution, 50 mL of brine
  2. dry with materialdried over Na2SO4
  3. filtrationFiltration and concentration
  4. customyielded a crude product which
  5. customwas purified on silica gel column with EtOAc

出典と根拠

ORDレコード
ord-e0838c2275984ab18cf52b098eec8ca5
出典データセット
uspto-grants-2014_12
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08921368B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート